We have developed an approach to directly probe neuronal excitability during the period beginning with induction of global ischemia and extending after reperfusion using transgenic mice expressing channelrhodopsin-2 (ChR2) to activate deep layer cortical neurons independent of synaptic or sensory stimulation. Spontaneous, ChR2, or forepaw stimulation-evoked electroencephalogram (EEG) or local field potential (LFP) records were collected from the somatosensory cortex. Within 20 s of ischemia, a Ͼ90% depression of spontaneous 0.3-3 Hz EEG and LFP power was detected. Ischemic depolarization followed EEG depression with a ϳ2 min delay. Surprisingly, neuronal excitability, as assessed by the ChR2-mediated EEG response, was intact during the period of strong spontaneous EEG suppression and actually increased before ischemic depolarization. In contrast, a decrease in the somatosensory-evoked potential (forepaw-evoked potential, reflecting cortical synaptic transmission) was coincident with the EEG suppression. After 5 min of ischemia, the animal was reperfused, and the ChR2-mediated response mostly recovered within 30 min (Ͼ80% of preischemia value). However, the recovery of the somatosensory-evoked potential was significantly delayed compared with the ChR2-mediated response (Ͻ40% of preischemia value at 60 min). By assessing intrinsic optical signals in combination with EEG, we found that neuronal excitability approached minimal values when the spreading ischemic depolarization wave propagated to the ChR2-stimulated cortex. Our results indicate that the ChR2-mediated EEG/LFP response recovers much faster than sensory-evoked EEG/LFP activity in vivo following ischemia and reperfusion, defining a period where excitable but synaptically silent neurons are present.
Introduction
Stroke is a major cause of death and disability that results from a transient or permanent reduction in cerebral blood flow (Dirnagl et al., 1999; Hossmann, 2006; Murphy and Corbett, 2009) . During stroke, neuronal structure and function are rapidly damaged (Risher et al., 2010; Mostany and PorteraCailliau, 2011) , but can in part recover during reperfusion Li and Murphy, 2008; Murphy et al., 2008) . Although structure can recover after reperfusion, brain activity is depressed as measured by spontaneous cortical electroencephalogram (EEG) activity or somatosensory-evoked potential (Astrup et al., 1981; Lesnick et al., 1986) . It is unclear whether this prolonged depression is due to a lack of a hyperpolarized membrane potential (Xu and Pulsinelli, 1994) or a defect that selectively impairs excitability or synaptic transmission (Gao et al., 1998) . Since ischemia can affect upstream sensory or presynaptic pathways (Pang et al., 2002; Li et al., 2009) , or enhance inhibition (Clarkson et al., 2010) , sensation is not always a reliable means for assessing excitability. Electrophysiological measurements involving direct antidromic neuronal stimulation may be difficult to employ and interpret in vivo. Here, we selectively examine neuronal excitability during the period beginning with the induction of ischemia and extendingafterreperfusionusingtransgenicmice[B6.Cg-Tg(Thy1-COP4/EYFP)18Gfng/J] expressing channelrhodopsin-2 (ChR2) in predominantly layer 5 cortical pyramidal neurons (Arenkiel et al., 2007; Wang et al., 2007; Ayling et al., 2009 ). ChR2 is a directly light-gated nonselective cation channel, which when expressed in neurons can transduce light energy into neural activity (Nagel et al., 2003; Boyden et al., 2005; Miesenböck, 2009) . With conventional EEG and multichannel local field potential (LFP) as readouts, the ChR2-based technique can optically interrogate defined circuit elements with millisecond-scale, and cell type-specific precision in vivo . This optogenetic approach has the advantage of being able to directly assess neuronal excitability independently of changes to synaptic activity. In addition, we use a mouse in vivo global ischemia model that allows us to titrate the duration of ischemia to within seconds and can rapidly alternate between the initiation of ischemia or reperfusion Liu and Murphy, 2009) . Using this approach within the sensorimotor cortex, we show that prolonged postischemic depression of sensory-evoked activity is not attributed to a loss of neuronal excitability since ChR2-mediated EEG responses are recovered following reperfusion.
Materials and Methods
Transgenic mice. We have studied a total of 24 adult male Thy1-ChR2-yellow fluorescent protein (YFP) transgenic mice [B6.Cg-Tg(Thy1-COP4/EYFP)18Gfng/J; Fig. 1 A, ChR2-YFP expression) (Arenkiel et al., 2007) , which were obtained from Jackson Laboratories and bred at the University of British Columbia animal facilities. The mice were 2-4 months of age and ranged in weight between 26 and 32 g. All experiments used urethane anesthesia, as in Murphy et al., (2008) . Body temperature was maintained at 37 Ϯ 0.5°C using a heating pad and feedback regulation from a rectal temperature probe (FHC). Hydration was maintained by intraperitoneal injection of saline (200 -300 l) with 20 mM glucose at 1-2 h intervals. The experimental protocols were approved by the University of British Columbia Animal Care Committee and were consistent with the Canadian Council on Animal Care and Use guidelines.
Surgical procedures. The surgical procedures for preparing a cranial window and the in vivo intrinsic optical signals (IOSs) imaging methods have been described previously . Briefly, animals were fitted into a custom-made head holder. A stainless steel chamber that covered mainly the right parietal cortex was adhered to the skull with ethyl cyanoacrylate (Krazy Glue, Elmer's Products). The animal was then prepared for a global ischemia model (see details in Murphy et al., 2008) . A 4 ϫ 4 mm cranial window was made over the somatosensory cortex, leaving the dura intact. The cortex was covered with 1.3% low-melt Figure 1 . EEG recording reveals selective deficits in sensory processing and rapid recovery of ChR2 response following reperfusion. A, Schematic drawing of experimental system. EEG recording, IOS imaging, photostimulation, and electrical forepaw stimulation were coordinated with synchronized trigger signals. ChR2 and sensory stimulation were interleaved and repeated every 10 s. Coronal brain slice indicates that ChR2 is predominantly expressed in layer 5 of cortex. B, Experimental timeline: ChR2 and sensory stimulation were performed during baseline, CCAO, reperfusion, and after the animal was killed (ϳ3 h for the timeline). Ci, Changes of spontaneous EEG (example mouse), DC potential (n ϭ 7 mice), 0.3-3 Hz EEG power (n ϭ 7 mice), forepaw-evoked potential (EP) (n ϭ 7 mice), and ChR2 peak amplitude (n ϭ 7 mice) are shown from top to bottom. In the EEG record, an enlarged view shows EEG depression within 20 s after CCAO (inset). Ischemic depolarization is indicated with an arrow over the DC potential record. Except for EEG and DC potential, the other statistical data were based on relative values, which were normalized with baseline level as 100%. The shaded band indicates SEM. Spontaneous EEG power and forepaw-evoked EEG response were depressed immediately after CCAO and recovered relatively slowly. However, ChR2 peak amplitude is transiently increased 1-2 min after occlusion, followed by a decrease in response and relatively rapid recovery with reperfusion. Cii, Six time segments of ChR2-/forepaw-evoked EEG data. The vertical dashed line indicates the onset of ChR2 or forepaw stimulation (a stimulus artifact is present during forepaw stimulation). The baseline responses of ChR2/forepaw stimulation are shown with dashed lines and superimposed over selected records. ChR2-mediated response shows a larger amplitude than the baseline (blue dash line) at 1 min after CCAO (trace 2), and relatively faster recovery at 30 min after CCAO. The forepaw-evoked potential shows prolonged suppression at 60 min after CCAO compared with the baseline response (red dash line). D, Statistical analysis of 0.3-3 Hz EEG power, forepaw-, or ChR2-mediated EEG responses during global ischemia at select time points. *p Ͻ 0.05; **p Ͻ 0.01. E, Forepaw/ChR2-mediated EEG responses are shown in phase plots for comparison to DC potential (n ϭ 7 mice). By setting a 15% level of excitable response as a threshold, a three-phase relationship was observed: phase 1 (shadowed with cyan), initiation of ischemia and suppression of response to 15% of baseline; phase 2 (shadowed with yellow), maximum inhibition; phase 3 (shadowed with pink), partial recovery of DC potential and excitable response. The primary motor cortex (M1) and hindlimb (sHL), forelimb somatosensory cortex (sFL), and secondary somatosensory cortex (S2) are indicated. Stim, Stimulation.
agarose (at 37-38°C; Type 3-A; A9793; Sigma) dissolved in HEPESbuffered artificial CSF (ACSF) and sealed with a glass coverslip (#1). For optrode recording (described below), a smaller cranial window (2 ϫ 2 mm) was made to cover the forelimb cortex with ACSF filling a well made of dental cement without a coverslip. A tracheotomy was performed on all animals to alleviate breathing problems, which may have been confounded by surgical manipulation of the tissue within the neck region or prolonged urethane anesthesia . After surgery, the animal was allowed to recover (under anesthesia) for at least 30 min before further experimental recording.
Global ischemia model. The common carotid arteries (CCAs) were exposed bilaterally and sutures (5-0, silk; Ethicon) were looped around each CCA. The animal was turned upright, placed in a head holder, and the craniotomy procedure performed. To induce global ischemia, we carefully pulled on both sutures and secured them with tape to induce bilateral CCA occlusion (CCAO). Ischemia was induced 15-40 min after EEG recording, and IOS imaging (or optrode recording) was begun. For experiments using EEG recordings with forepaw or ChR2 stimulation, only animals exhibiting Ͼ8 mV of DC shift were considered as successful global ischemia models. To avoid compromising the health of the animals, we limited the ischemic period to ϳ5 min, and animals were reperfused by cutting the sutures. After 1-1.5 h of reperfusion, the animal was killed with an intraperitoneal injection of Euthanyl (0.10 ml) (Figure  1 B, timeline).
ChR2 stimulation. f (CNI Optoelectronics) was used to stimulate ChR2-expressing neurons. The relatively collimated laser beam was delivered to the brain surface via an Olympus BX51 upright microscope, and the diameter measured through the objective (4ϫ) was 43 m at the brain surface (Fig.  1A , n ϭ 7 mice). The beam was positioned over the somatosensory cortex as determined by stereotaxic coordinates. Laser output ϳ1 mW premeasured with a power meter (Thorlabs) was triggered by a transistor-transistor logic pulse of 5 ms duration for each photostimulation (Arenkiel et al., 2007; Ayling et al., 2009 ). The power was ϳ700 mW/mm 2 at brain surface. Based on previous work addressing light spreading and scattering in brain tissue (Aravanis et al., 2007; Kahn et al., 2011) , the laser power at the depth of layer 5 (800 m, where most ChR2-YFP-labeled neuronal cell bodies were found) was expected to be ϳ6 mW/mm 2 ; however, light levels at superficial dendrites were likely much higher. Laser power for ChR2 stimulation was adjusted (1-5 mW) following one to two pilot trials to obtain a Ն0.5 mV peak EEG response, which was measured with a surface electrode.
Forepaw stimulation. Two metal pins were inserted into the left forepaw, and a 1-5 mA 1 or 2 ms electrical pulse was delivered. The electrical pulse was generated by a constant current stimulus isolator (A385, World Precision Instruments) triggered 5 s after ChR2 laser stimulation by a 1322A Digidata system (Molecular Devices).
EEG recording. For EEG recording, a Teflon-coated chlorided silver wire (125 m; World Precision Instruments) with an exposed tip (ϳ1 mm) was placed on the cortical surface within the agarose. For EEG recording combined with optrode recording, the EEG electrode was placed in the ACSF and the reference electrode was placed on the nasal bone under the skin Mohajerani et al., 2010) . The cortical signal was amplified and filtered (gain 100ϫ, 0 -1000 Hz) using a differential amplifier (DAM50, World Precision Instruments) and digitized (1000 Hz) using the 1322A Digidata. The output from the DAM50 amplifier was also sent to a USB-based device (MiniDigi 1A, Molecular Devices) then acquired by an Axoscope 9.2 (Molecular Devices) for continuous recording. In our experiment, Clampex software was used as the central controller for timing the experimental system.
Optrode recording. To obtain information from different cortical depths, a silicon optrode (A1x16-3 mm-50-413-Op16, NeuroNexus Technologies) was used for recording LFP and multiunit activity (MUA) and ChR2 stimulation in eight mice (Kravitz et al., 2010; Kahn et al., 2011) . The optrode contained 16 413 m 2 recording sites (0.7-1.2 M⍀ impedance at 1 kHz), arranged linearly with 50 m spacing between each site. A 473 nm laser (IKE-473-100-OP, IkeCool) was coupled to the optrode using a fiberoptic patch cord (FC-x.x-NNC, NeuroNexus Technologies). Based on the atlas of mouse cortex from the Allen Institute for Brain Science, the optrode probe was inserted into the forelimb somatosensory cortex to a depth of 800 m (bregma 0.3 mm, lateral 2.0 mm) to target layers 1-5. Here, ChR2 stimulation was performed with an optrode-integrated laser fiber (105 m diameter). The fiber tip was positioned ϳ50 m above the uppermost recording site near the cortical surface. Based on previous work with a similar probe (Kravitz et al., 2010) , laser power was adjusted to yield 0.5-2 mW at the fiber tip to obtain clear LFP deflections from the deepest recording site. In one preliminary experiment, laser power of 0.5-5 mW was systematically varied. The quantified LFP deflection showed a hyperbolic tangential increase with laser power (data not shown). By fitting to the tangential function, 0.5-2 mW laser power was found to evoke 72-99% of the maximum response. LFP recordings were performed from the optrode using a portable 16-channel data acquisition system (USB-ME16-FAI-System, Multi Channel Systems). After 1000ϫ amplification, all 16-channel LFP signals were sampled at 25 kHz with a bandwidth of 1-5000 Hz.
Pharmacology. Seven ChR2 mice were used for pharmacological experiments. For experiments (n ϭ 4) involving glutamate receptor antagonists, DNQX (200 M) and APV (500 M) (Sigma) were dissolved in ACSF and applied to the craniectomy. Experiments (n ϭ 3) using tetrodotoxin (TTX; 30 M, Sigma) used local microinjection within the craniotomy, and were performed under ketamine-xylazine anesthesia using a similar collimated laser delivery system (Ayling et al., 2009 ) with 10 ms laser pulses.
Electrophysiology analysis. Since CCAO caused a DC shift during the recording Tran et al., 2012) , linear fitting was used to remove the shifting baseline of EEG signal. The continuous EEG recording from the Axoscope was performed routinely with off-line highpass filtering (0.1 Hz, Bessel filter, 8 pole) to exclude the slow DC shift. EEG power of 0.3-3 Hz was calculated from the filtered EEG signal (only 4.5 s of data between ChR2 and forepaw stimulation in each period were used to avoid stimulation interference) with the frequency domain filtered to 0.3-3 Hz . The amplitude from ChR2 stimulation was defined as the minimum EEG signal within 40 ms after onset of ChR2 stimulation. To reduce the photoelectric artifact (Ayling et al., 2009) , the ChR2 responses were corrected by subtracting ChR2 responses obtained 10 min after the death of the animal. For forepaw electrical stimulation, the evoked potential was extracted from linear corrected EEG data by determining the minimum value within 20 ms after stimulation. Forepaw-evoked potentials were averaged over 1 min. Only the amplitude of the large primary cortical wave was determined (Lesnick et al., 1986) , which corresponded to the N1 wave (Fujioka et al., 2004) .
For 16-channel optrode recording, 50 ms columnar ChR2 and sensory-evoked LFP responses were segmented to display data from baseline, during occlusion, and after reperfusion. To quantify the ChR2-mediated LFP responses, the minimum voltage value of 8 -12 ms after the ChR2 stimulation onset was extracted. For sensory-evoked LFP responses, the minimum of 10 -20 ms after the forepaw stimulation onset was calculated. Since the bandwidth of LFP recording was 1-5000 Hz, the mean power of 1-3 Hz was calculated as previously (Mohajerani et al., 2010) . Only LFP data from 500 m depth (beginning in layer 5) were quantified for group data. To resolve spikes from LFP recording, off-line bandpass filtering (600 -6000 Hz, elliptic filter) was performed to acquire MUA (Kahn et al., 2011) . Automated amplitude thresholding (four times the SD of the background noise) was used to detect spikes from the filtered data (Quiroga et al., 2004) . Relatively large laser stimulation artifacts were removed by setting another upper-bound threshold (40 times SD). To reduce possible false-positive spikes, a principal component analysis was used to extract features of spike shapes that were used for excluding outliers (Bokil et al., 2010) . The selected spikes were presented in a raster plot. The open source program Wave Clus (Quiroga et al., 2004) was used for this analysis.
IOS imaging. For IOS imaging, the cortical surface was illuminated by red light-emitting diodes (center at 635 nm) mounted around a microscope objective . Imaging was performed with a charge-coupled device (CCD) camera (1M60 Pantera, Teledyne DALSA), and EPIX E4DB frame grabber. The 12-bit CCD camera used for IOS was mounted on an Olympus BX51 upright scope with a 4ϫ, 0.13 numerical aperture UPlan Fl Olympus objective. We typically imaged an area of 3.2 ϫ 3.2 mm using a 4 ϫ 4 pixel binning mode (i.e., 256 ϫ 256 pixels for one single image, with a pixel size of 12.5 ϫ 12.5 m). IOS imaging was not performed during optrode recording experiments.
Image analysis. To visualize the ischemic depolarization waves, a differential image method for processing the image sequence was performed as in previous work (Chen et al., 2006a,b) . Within an image sequence, we selected two small regions of interest (ROIs) (5 ϫ 5 pixel size) located in the cortical parenchyma. The average reflectance intensity in the ROI of each frame was calculated. Choosing the reflectance before ischemic depolarization onset as the baseline value, we calculated the relative changes of reflectance during an ischemic depolarization event.
Statistics. In the 17 animal experiments for global ischemia, 15 of the animals permitted successful recording of both consistent ChR2 and forepaw stimulation responses (DC shift Ͼ8 mV). Two of the 17 animals did not show a typical DC shift after CCAO. Only data from 15 animals that produced clear DC shifts were used for statistical analysis. Except for DC potential, the other statistical variables (e.g., EEG power and ChR2 peak amplitude) were based on normalized relative values. The mean baseline level values before CCAO 15 min from each animal were used to normalize the absolute measurements. All group data were expressed as the mean Ϯ SEM. Phase plots were created by plotting the mean values for forepaw and ChR2-mediated EEG amplitude on the y-axis and DC potential on the x-axis for each point in time (Ba et al., 2002) . A Student's t test was used for testing whether the group data showed significant changes at different time points relative to the baseline level 100%. Values were considered statistically significant at p Ͻ 0.05.
Results

EEG analysis of cortical excitability during global ischemia using ChR2
Here we adapt a mouse model of global ischemia Liu and Murphy, 2009; Tran et al., 2012) for direct optogenetic activation of subpopulations of cortical neurons from B6.Cg-Tg(Thy1-COP4/EYFP)18Gfng/J ChR2 transgenic mice before, during, and after global ischemia. These mice express ChR2 in predominantly cortical layer 5 (Arenkiel et al., 2007; Wang et al., 2007; Ayling et al., 2009; Kahn et al., 2011) (Fig. 1 A) . Given the diffuse labeling that is also present, we cannot rule out that a minority of expression occurs in other layers. The global ischemia model permits the induction of ischemia and reperfusion while retaining access to the cortical surface for light stimulation of ChR2 or imaging (Murphy, 2011) (Fig. 1 A) . ChR2 was used to assess neuronal excitability independent of sensory stimulation every 10 s during baseline, ischemia, and reperfusion in combination with electrophysiological methods. During periods of baseline activity in preischemic animals, we observed a regular EEG signal consisting of ϳ0.3-3 Hz activity, which is expected with urethane anesthesia (Crunelli and Hughes, 2010; Mohajerani et al., 2010; Barth and Mody, 2011) . Bilateral CCAO (ϳ5 min) resulted in a rapid suppression of EEG activity within 20 s, consistent with previous reports (n ϭ 7 mice; Fig. 1Ci ). Following the EEG depression with a ϳ2 min delay, an ischemic depolarization characterized by a shift in DC potential was observed (amplitude: ϳ8 -18 mV; duration: 7-10 min) (Fig. 1Ci ). There was a small transient hyperpolarization (1-2 mV) of DC potential before the negative DC potential shift (depolarization), consistent with previous work (Xu and Pulsinelli, 1994) . Given these robust EEG changes, the loss of a normal cortical EEG was used as a marker of ischemic onset. Following reperfusion, the DC potential partially recovered within 10 min (to Ϫ5.7 Ϯ 1.2 mV, n ϭ 7) (Fig. 1Ci) . However, spontaneous EEG power quantified over 0.3-3 Hz showed relatively slower recovery. Even 1 h after CCAO, EEG power was Ͻ40% of baseline levels.
While simultaneously monitoring the spontaneous EEG and forepaw sensory response, ChR2 stimulation was used to assess neuronal excitability by measuring the depolarizing (negative going) EEG response to light (Fig. 1Cii) . Brief 5 ms pulses of 473 nm light produced a depolarizing EEG response that contained components expected from rapid (within 15-25 ms) direct ChR2 activation (Ayling et al., 2009) , as well as delayed responses that may reflect secondary activation of neurons through synaptic transmission (Harrison et al., 2012; Scott and Murphy, 2012) . During baseline EEG recordings (15-40 min before CCAO), the ChR2 response peak from each 5 ms 473 nm laser stimulation pulse was 0.5-2 mV and occurred ϳ15-25 ms after stimulation. Forepaw stimulation (1 ms electrical pulse)-evoked EEG responses had a peak amplitude of ϳ0.05-0.10 mV that occurred ϳ15-20 ms after electrical stimulation in animals before ischemia. The peak ChR2-mediated EEG response was used as a measure of neuronal excitability. Within 1 min after occlusion, the forepaw-evoked response was blocked, while the ChR2-mediated response was preserved (Fig. 1Cii) . Surprisingly, neuronal excitability as monitored by ChR2 and EEG was intact during the first 2 min of global ischemia despite strong suppression of spontaneous EEG activity. The ChR2-mediated EEG response actually increased 1 min following occlusion before ischemic depolarization (Fig. 1Cii) . Both ChR2 and forepaw-evoked responses were markedly suppressed within 3 min of CCAO. During reperfusion after 5 min of ischemia, the ChR2-mediated EEG response showed faster recovery than the forepaw-evoked response (Fig. 1 D) .
Relationship between DC potential and excitability assessed using ChR2
To examine the relationship between neuronal excitability (measured by forepaw-or ChR2-mediated responses) and ischemic depolarization, phase plots were constructed (Fig. 1 E) . Specifically, the phase plots were used to graphically display how changes in the ChR2-mediated or sensory-evoked EEG response were related to DC potential during ischemia and reperfusion in group data. By setting a 15% level of excitable response as a threshold, a three-phase relationship was observed: phase 1, initiation of ischemia and suppression of response to 15% of baseline; phase 2, maximum inhibition; and phase 3, recovery during reperfusion. The forepaw-evoked EEG response showed a rapid decrease even before a change in DC potential was observed during phase 1, while the ChR2 measure of EEG excitability was relatively unaffected. Interestingly, during phase 1 the ChR2-mediated EEG response was gradually attenuated in proportion to the loss of DC potential. The use of linear regression indicated that the loss of DC potential and the ChR2 response were strongly correlated (r ϭ 0.93, p Ͻ 0.01), while DC potential and forepaw response were not (r ϭ 0.05, p Ͼ 0.05). During phase 3, DC potential gradually recovered and an approximately proportional return of the ChR2-mediated response was observed (r ϭ 0.91, p Ͻ 0.01). However, the recovery of the forepaw-evoked response during phase 3 was significantly delayed and incomplete despite the recovery of DC potential (Fig. 1 E) . The use of phase plots indicates that changes in excitability assessed by the ChR2-mediated EEG response are strongly correlated with the DC potential, while the forepaw-evoked or spontaneous EEG response shows defects that precede the loss of DC potential and are still apparent even after the DC potential has appreciably recovered (Fig. 1 E) .
LFP characterization of ChR2-and sensory-evoked responses during global ischemia
Although surface EEG recording showed robust changes in both sensory and ChR2 responses following global ischemia, it was not clear whether these effects were present throughout the depth of cortex. Using a 16-channel optrode, we monitored spontaneous, sensory, and ChR2-mediated changes in LFP within cortical layers 1-5 (Fig. 2 A) . Before CCAO, we observed a robust spontaneous LFP signal, consisting primarily of relatively low-frequency ϳ1-3 Hz activity. After 1 min of CCAO, the forepaw-evoked and spontaneous LFP signals were suppressed, but the ChR2-mediated peak LFP response was preserved across cortical depth (Fig. 2 Bi,Bii). Analysis of ChR2-mediated response recovery (during reperfusion), using LFP sweeps that were stacked to form images, indicated that all depths exhibited relatively faster and more complete recovery than the forepaw-evoked response (Fig.  2C ). Since the ChR2 was expressed predominantly in layer 5, we selected the LFP signal from the 500 m depth recording site to quantify the changes during global ischemia within the group data (Fig. 2 D) . Plotting the ChR2 response from layer 5 indicated nearly full recovery of the ChR2-mediated response after 7-10 min of reperfusion (Ͼ90% of baseline level), but only minimal recovery of the sensory-evoked LFP response (Fig. 2 D) . In additional longer term recording experiments (n ϭ 4 mice) with stronger forepaw stimulation (2 ms), we found greater recovery of the forepaw-evoked LFP response 2 h after reperfusion (77 Ϯ 21% of baseline level, n ϭ 4, p ϭ 0.36), consistent with previous data examining sensory maps . Using stronger sensory stimulation, we were also able to better match the amplitude of the optogenetic and sensory responses (0.67 Ϯ 0.19 mV optogenetic vs 0.52 Ϯ 0.07 mV forepaw, n ϭ 4, p ϭ 0.53), and confirmed that the sensory response was consistently depressed at 30 min after reperfusion (36 Ϯ 7% of baseline level, n ϭ 4, p Ͻ 0.01), while the optogenetic response recovered to 103 Ϯ 5% of baseline level at 30 min (n ϭ 4, p ϭ 0.60).
To investigate the nature of the ChR2-evoked response, we performed additional LFP analysis and parallel pharmacological experiments. Data obtained from all 16 channels were bandpass filtered (600 -6000 Hz) to isolate spike activity that spontaneously occurred or was evoked in response to ChR2 or sensory stimulation (Fig.  3A,B) . Despite the laser entering at the brain surface, we detected an increase in spikes evoked by ChR2 stimulation from electrodes within layer 5. Although ChR2 is expressed at highest density within layer 5 neuron cell bodies, laser stimulation is likely to predominantly activate superficial dendritic tufts. The spiking is consistent with a direct activation of ChR2-expressing neurons (Kahn et al., 2011) . Consistent with a component of lightstimulated signals being dependent on action potentials, locally applied TTX led to a 67% reduction in ChR2-evoked EEG signal (Fig. 3C) . To assess the contribution of synaptic transmission, we applied DNQX and APV locally and observed a complete blockade of the depolarizing forepaw-evoked signal, but no significant effect on the ChR2-evoked peak EEG response (Fig. 3D) .
Spatiotemporal evolution of ischemic depolarization and relation to ChR2-mediated responses
Changes in cortical absorbance triggered by ischemic depolarization can be detected using IOS imaging (Obeidat et al., 2000; Jarvis et al., 2001; . IOSs were acquired to examine the relationship between ischemic depolarization and excitability as assayed by ChR2 stimulation and EEG recording (Fig. 4 A) . When the spreading ischemic depolarization IOS wave propagated to the ChR2-stimulated cortex [ Fig. 4 B, C, ROI 2 (R2)], the EEG response was rapidly reduced. IOS imaging showed that the ischemic depolarization wave started as an increase in scattering (Fig. 4C, white) from the most anterior and lateral portions of the imaged cortex and spread posteriorly and medially . At the 140 s time point, the maximum change of IOS occurred in R2 (Fig.  4 B, C ) and was coincident with the maximally attenuated ChR2-mediated EEG response (Fig. 4 A) . Analysis of group data (n ϭ 7 mice) confirmed the coincidence between local ischemic depolarization and the loss of excitability with a temporal precision of 5 Ϯ 1 s.
Discussion
ChR2-based assessment of neuronal excitability during global ischemia Preservation of neuronal excitability is critical for functional recovery after stroke (Bü tefisch et al., 2003; Murphy and Corbett, 2009; Clarkson et al., 2010) . Previous data have shown that synaptic transmission is depressed during ischemia and following reperfusion (Xu and Pulsinelli, 1996; Gao et al., 1998) . This effect can be measured using cortical EEG recordings (Astrup et al., 1981) that presumably reflect synaptic activity. However, it has been a challenge to directly assess neuronal excitability in vivo while EEG activity is depressed during ischemia and within 1 h after reperfusion. Conven- tional recording of sensation-evoked potentials has revealed hyperexcitability from time points 1-6 h after focal ischemia (Fujioka et al., 2004) . Neuronal excitability can be assessed indirectly in vivo after stroke or trauma using paired-pulse sensory stimulation (Fujioka et al., 2004; Ding et al., 2011) . However, previous work has shown that the cortical sensoryevoked potential is abolished after global ischemia (Lesnick et al., 1986) . We have used ChR2 to directly depolarize neurons and extend the previous measurement of cortical excitability with embedded stimulating electrodes (Lesnick et al., 1986) . We expect ChR2 to be predominantly expressed in layer 5 cortical pyramidal neurons (Arenkiel et al., 2007; Wang et al., 2007; Ayling et al., 2009) . Therefore, the changes in neuronal excitability we observe during acute phases of global ischemia are relatively specific to these neurons. With optogenetics, we show that it would be feasible to study the excitability of select cell populations, such as large aspiny neurons (Pang et al., 2002; Li et al., 2009) or GABAergic interneurons (Redecker et al., 2002; Boyden et al., 2005; Clarkson et al., 2010) , during ischemia.
The global ischemia model used here is clinically related to cardiac arrest or cardiac surgery (Hofmeijer and van Putten, 2012) . Although this model does not recapitulate more clinically relevant middle cerebral artery occlusion models (Dirnagl et al., 1999) , we can precisely control the duration of ischemia to within seconds and can rapidly alternate between the initiation of ischemia or reperfusion. The methods used here could be extended to a focal ischemia model, but it would be difficult to monitor excitability within the first minutes of occlusion since these models are not necessarily compatible with continuous recording . Since it is possible to perform scanning stimulation (Ayling et al., 2009), we may be able to complete a spatial optogenetic analysis of a focal photothrombotic model (Mohajerani et al., 2011) . This would distinguish changes in excitability within specific regions such as the infarct, penumbra, and normal tissue (Chen et al., 2006b) . Additionally, it would be possible to study neuronal excitability with the recently developed hippocampal ischemia model (Barth and Mody, 2011) using in vivo fiber optic activation of ChR2. Given its wide applications, ChR2-based assessment of neuronal excitability could be a mouse analog of transcranial magnetic stimulation, providing background for translational stroke studies (Bütefisch et al., 2003) .
The nature of the ChR2-mediated electrophysiological signal The ChR2-mediated EEG or LFP response can reflect both direct ChR2-mediated and indirect synaptic activation, and can last longer than the duration of the light stimulus (Harrison et al., 2012; Lim et al., 2012) . Given the relatively long deactivation time for ChR2 (Fenno et al., 2011) , even the response to direct activation should be on the order of 10 -15 ms in duration, consistent with the peak responses we observe. Some of the indirect effects from light stimulation may be attributed to ChR2 directly gating channels on axons that produce neurotransmitter release (Petreanu et al., 2007; Schoenenberger et al., 2011) . However, the initial peak component of the ChR2-mediated response (within 10 -20 ms) was relatively insensitive to glutamate receptor antagonists and is likely derived from direct channel activation and secondary action potential firing given its sensitivity to tetrodotoxin. Therefore, ChR2-mediated peak EEG or LFP signals may predominantly reflect subthreshold activity and poorly synchronized firing among populations of neurons. . IOS imaging indicates that the ChR2-mediated EEG response is suppressed coincidently with the DC shift during global ischemia. A, Bar plot of ChR2-mediated peak EEG amplitude shows transient increase after spontaneous EEG suppression, but before the DC potential depolarized. When the DC potential indicated peak ischemic depolarization, the ChR2-mediated EEG amplitude decreased to minimal values. B, Ischemic depolarization (ID) wave characterized by a rapid increase in IOS signal. Five-point smoothed time plots for different regions of interest (R1 and R2, shown in the inset) indicate the propagation of the ischemic depolarization wave. R1 is close to the EEG recording electrode. R2 is from a site near laser stimulation (indicated by asterisk). Part of the time courses between Ϫ20 and 50 s were affected by motion artifacts associated with the CCAO procedure. C, Differential images of intrinsic signal show the spatiotemporal evolution of the ischemic depolarization wave. The ischemic depolarization wave starts typically as an increase in light scattering (shown as white) from the most anterior and lateral portions of the imaged cortex and spreads posteriorly and medially. When the IOS response peak is present at site R2 (at 140 s, see B and C), the ChR2 peak amplitude was reduced to a minimum value in A.
Selective deficits in sensory processing following reperfusion in mouse cortex
2009; Clarkson et al., 2010; Paz et al., 2010) . However, the results were not always consistent between models. Using assessment of forepaw stimulation-evoked cortical potentials, we find that forepaw sensation-dependent cortical synaptic transmission was inhibited even 1 h after reperfusion from CCAO. This finding was consistent with previous work (Astrup et al., 1981; Murphy et al., 2008) and may reflect a persistent synaptic transmission defect (Bolay and Dalkara, 1998) . In contrast to synaptic responses, the use of ChR2 stimulation revealed that neuronal excitability was recovered with reperfusion. These results suggest that the selective deficits in sensory processing following reperfusion in mouse cortex are not necessarily attributed to a loss of direct neuronal excitability. The absence of forepaw-evoked and spontaneous EEG or LFP responses is indicative of a loss of synaptic activity. This fact, combined with the ability to depolarize neurons with light in ChR2 transgenic mice, argues for a long-term selective block in synaptic transmission during the postreperfusion period.
The mismatches between changes within sensory processing and neuronal excitability after transient global ischemia may be due to a block of conduction within white matter (including thalamus) (Lesnick et al., 1986) . The short-latency forepaw response (within 20 ms of forepaw stimulation) we quantified is likely to be directly related to thalamocortical activity (Wu et al., 2012) . Further research may focus on functional changes within thalamocortical projections during stroke (Paz et al., 2010) by performing direct thalamic recordings (Ding et al., 2011) . Moreover, it is also possible that postsynaptic cortical mechanisms are involved in the ischemia-induced loss of synaptic activity such as glutamate receptor endocytosis (Man et al., 2000) .
Ischemic depolarization is associated with a loss of neuronal excitability
Previous work has shown that ischemic depolarization is the major trigger of neuronal structural damage (Obeidat et al., 2000; Murphy et al., 2008; Risher et al., 2010) during stroke. Here we show that ischemic depolarization is directly related to the loss of neuronal excitability measured by ChR2-mediated EEG responses. Ischemic depolarization is initiated at the edge of the ischemic core by elevated [K ϩ ] o and glutamate (Nedergaard, 1996; Lee et al., 1999; Strong and Dardis, 2005) . Since both K ϩ and glutamate may excite neurons, this could be why we observed a transient increase in neuronal excitability within 1 min after CCAO. In our experiments, 5 min of CCAO would induce a DC shift of ϳ10 min in duration, about three times longer than normoxic spreading depression (Leao, 1944) induced in healthy brain. The prolonged collapse of ion gradients during ischemic depolarization could initiate a cascade of damaging events (Dirnagl et al., 1999 ) that lead to prolonged inhibition of forepaw sensory responses. The dependence of ChR2 responses on an intact resting membrane potential (Nagel et al., 2003) is consistent with its strong inhibition during ischemic depolarization and rapid recovery during reperfusion.
Although the DC potential did not completely return to baseline levels after reperfusion, the ChR2 peak amplitude recovered nearly fully when compared with the ischemic depolarization process. It is possible that this reflects hyperexcitability that is observed after stroke, which enhances the ChR2 response despite incomplete recovery of membrane potential (Fujioka et al., 2004) . This may be related to a reduction in GABA A receptor expression after stroke (Schiene et al., 1996; Redecker et al., 2002 ). More work is also needed to determine whether GABA A receptor-mediated tonic inhibition plays a role (Clarkson et al., 2010) .
In both experimental and clinical studies, recurring ischemic depolarization or spreading depression waves have been associated with an exacerbation of damage after stroke (Dirnagl et al., 1999; Jarvis et al., 2001; Dreier et al., 2006; Shin et al., 2006; Strong et al., 2007; Risher et al., 2010) . In vitro data indicate that ischemic depolarization can alter the balance between excitation and inhibition (Berger et al., 2008) . Our study supports the idea that agents that reduce ischemic depolarization are potential therapeutic targets for stroke (Douglas et al., 2011; Risher et al., 2011) . Reducing ischemic depolarization will help to maintain excitability and may prevent prolonged loss of sensory processing, leading to better outcomes following reperfusion.
In summary, our results indicate that neuronal excitability recovers much faster than sensory-evoked synaptic activity in vivo following ischemia and reperfusion. This delineates a time window following ischemia where synaptically silent, yet excitable neurons are present. We anticipate that optogenetically stimulated ChR2 will allow investigators to further examine the excitability of unique cell populations during ischemic damage and reperfusion.
